Literature DB >> 26401851

Substitution urethroplasty or anastomotic urethroplasty for bulbar urethra strictures? Or endoscopic urethrotomy? Opinion: Anastomotic Urethroplasty.

Jordan A Siegel1, Allen F Morey1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26401851      PMCID: PMC4756987          DOI: 10.1590/S1677-5538.IBJU.2015.0266

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


× No keyword cloud information.

INTRODUCTION

With an estimated prevalence of 296 to 627 per 100,000 men, male urethral stricture disease imposes a significant burden on the health care system (1, 2). Urethroplasty has demonstrated durable, high success rates in the management of a wide spectrum of stricture disease, far exceeding that of the more commonly performed but less successful direct vision internal urethrotomy (DVIU) (1, 3–5). While procedure selection depends on stricture characteristics (length, location, and etiology), the high success rate of excision and primary anastomotic (EPA) urethroplasty makes it the procedure of choice for most strictures of the bulbar urethra (6). However, concerns regarding the effect of urethral transection on male sexual health has led some centers to advocate for substitution urethroplasty (7), likely contributing to an increase in these procedures (8). Our objective is to review the literature supporting EPA urethroplasty in strictures of the bulbar urethra.

Success of EPA urethroplasty

A 25-year meta-analysis of the contemporary EPA urethroplasty literature demonstrates a uniformly high level of success (>90%) for EPA of bulbar strictures (6), superior to the results of any other method of bulbar urethroplasty (9, 10). In fact, a 4-fold increase in stricture recurrence has been reported in substitution urethroplasty when compared with EPA (11). While attempts to demonstrate equivalency between substitution urethroplasty and EPA have been reported, these studies suffer from patency rates that fall short of that ordinarily reported for EPA, as well as discrepant follow up between treatment groups (12). Unfortunately, DVIU remains the most frequently used treatment for anterior urethral stricture, despite its inferior results compared to urethroplasty (1, 3, 13). This is often attributed to the simplicity and speed of endoscopic treatment and a lack of urologists trained in urethroplasty techniques, especially in various rural geographic locations (2, 14). At best, initial DVIU for short, non-traumatic strictures of the bulbar urethra has been associated with a success rate of only 39-73%, with subsequent attempts performing even worse (4, 5, 15). It is clear that after prior failed urethrotomy the complexity of the stricture increases (16). Current recommendations allow for a single attempt at DVIU in a well-selected patient before referring stricture patients for definitive urethroplasty (17, 18).

UTSW EPA experience

Our experience with EPA has been uniformly favorable and mirrors that of other large institutional series (11, 19, 20). Review of our institutional database (2007-2014) identified 348 patients who underwent bulbar EPA urethroplasty, the most common technique utilized at our facility (35% of all urethroplasties). Success, defined as the absence of any additional urethral instrumentation, was achieved in 325/348 (93.4%) patients, a rate on par with that of the contemporary literature (6). Patient follow up averaged 39.4 months and stricture length averaged 2.1 cm. Given its durable success rate, we perform EPA urethroplasty whenever possible, even in the re-operative setting. Our EPA technique emphasizes complete scar excision, while maintaining the vascular integrity of the spongiosum. Though EPA failure is rare, it is our belief that many failures are caused by inadequate proximal urethral dissection, leading to incomplete resection of diseased tissue. In order to optimize the proximal dissection, we utilize antegrade instrumentation via a suprapubic tract (if present), or retrograde placement of a guidewire, which aides in the identification of the proximal lumen. With control and adequate visualization of the proximal urethral stump, the strictured mucosa and associated spongiofibrosis is completely excised, leaving well-vascularized urethral tissue for a healthy anastomosis. We advocate performing a two-layer ventral anastomosis after urethral transection for precise re-approximation of the robust vasculature of the ventral spongiosum. We avoid additional maneuvers such as corporal splitting whenever possible, as they may further compromise antegrade and retrograde corporal blood flow to the urethra. Instead, we facilitate urethral lengthening by aggressively mobilizing the urethra from its ventral scrotal attachments while preserving dorsal perforating vasculature as much as possible. Our results underscore the value of incorporating these various alter-native technical measures to avoid urethral ischemia. Adequate urethral length after transection is essential for a tension-free anastomotic repair. Despite traditional recommendations that the EPA technique be limited to strictures 2 cm or less long (21), our experience suggests that this underestimates the potential urethral length that can be mobilized via a perineal dissection (22). Male urethra has been shown to be exceptionally extensible, with a possible additional 65% of length obtained after mobilization, allowing for a tension-free anastomosis even in longer strictures (23). It has been our experience that up to 5 cm resection is possible in the proximal bulb (lower half of perineal incision) in selected favorable cases; a 2 cm limit is more customary in the distal bulb (upper half of perineal incision).

Complications of EPA urethroplasty

Contemporary analysis of urethroplasty in the United States reveals a low post––operative complication rate of 6.6% (8). Compared to anastomotic urethroplasty, substitution urethroplasty is associated with a 5-fold increase in complications, though direct comparisons of the complication profiles are scant (11). It is clear however, that anastomotic repairs obviate the time and trauma needed for harvesting of flap or graft, thus avoiding those inherent complications (24, 25). The complication of erectile dysfunction after anterior urethroplasty is a controversial topic with many divergent opinions (7). Overall, urethroplasty has been shown to cause transient post-operative erectile functional decline in up to 40% of patients (26). Multiple risk factors appear to be involved, such as patient age, stricture length and location, and type of reconstruction (26–28). While ED in anastomotic repairs has been shown to be significantly higher at three months post-operatively (26, 28, 29), there is no demonstrable difference at 6 months and beyond (26, 28, 30–35). In fact, overall sexual dysfunction after urethroplasty lasting beyond 6 months has been shown to be on par with circumcision (27).

CONCLUSIONS

Excision and primary anastomotic urethroplasty demonstrates the highest long-term success rate among available techniques for bulbar urethral strictures. The overall complications of EPA are low, and erectile dysfunction, if encountered, generally resolves after six months of recovery. EPA should be considered the gold standard in treatment of bulbar strictures.
  35 in total

Review 1.  SIU/ICUD Consultation on Urethral Strictures: Anterior urethra--primary anastomosis.

Authors:  Allen F Morey; Nick Watkin; Ofer Shenfeld; Ehab Eltahawy; Carlos Giudice
Journal:  Urology       Date:  2013-12-27       Impact factor: 2.649

Review 2.  SIU/ICUD Consultation on Urethral Strictures: The management of anterior urethral stricture disease using substitution urethroplasty.

Authors:  Christopher Chapple; Daniela Andrich; Anthony Atala; Guido Barbagli; André Cavalcanti; Sanjay Kulkarni; Altaf Mangera; Yosuke Nakajima
Journal:  Urology       Date:  2014-01-08       Impact factor: 2.649

3.  Trends, utilization, and immediate perioperative complications of urethroplasty in the United States: data from the national inpatient sample 2000-2010.

Authors:  Sarah D Blaschko; Catherine R Harris; Uwais B Zaid; Tom Gaither; Carissa Chu; Amjad Alwaal; Jack W McAninch; Charles E McCulloch; Benjamin N Breyer
Journal:  Urology       Date:  2015-03-04       Impact factor: 2.649

4.  Erectile function after anterior urethroplasty.

Authors:  J W Coursey; A F Morey; J W McAninch; D J Summerton; C Secrest; P White; K Miller; C Pieczonka; D Hochberg; N Armenakas
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

5.  Urethral extensibility applied to reconstructive surgery.

Authors:  E Alexsandro Da Silva; Francisco J B Sampaio
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

6.  Erectile dysfunction post-perineal anastomotic urethroplasty for traumatic urethral injuries: analysis of incidence and possibility of recovery.

Authors:  Ahmed El-Assmy; Ahmed M Harraz; Mohammed Benhassan; Mohamed Fouda; Hady Gaber; Adel Nabeeh; El Housseiny I Ibrahiem
Journal:  Int Urol Nephrol       Date:  2015-03-17       Impact factor: 2.370

7.  Substitution urethroplasty is as successful as anastomotic urethroplasty for short bulbar strictures.

Authors:  Mang L Chen; Brian D Odom; Richard A Santucci
Journal:  Can J Urol       Date:  2014-12       Impact factor: 1.344

8.  Prediction of early and late complications after oral mucosal graft harvesting: multivariable analysis from a cohort of 553 consecutive patients.

Authors:  Guido Barbagli; Nicola Fossati; Salvatore Sansalone; Alessandro Larcher; Giuseppe Romano; Vincenzo Dell'Acqua; Giorgio Guazzoni; Massimo Lazzeri
Journal:  J Urol       Date:  2013-09-11       Impact factor: 7.450

9.  Long-term followup and deterioration rate of anterior substitution urethroplasty.

Authors:  Guido Barbagli; Sanjay B Kulkarni; Nicola Fossati; Alessandro Larcher; Salvatore Sansalone; Giorgio Guazzoni; Giuseppe Romano; Joshi M Pankaj; Vincenzo Dell'Acqua; Massimo Lazzeri
Journal:  J Urol       Date:  2014-02-15       Impact factor: 7.450

10.  High regional variation in urethroplasty in the United States.

Authors:  Bradley D Figler; John L Gore; Sarah K Holt; Bryan B Voelzke; Hunter Wessells
Journal:  J Urol       Date:  2014-07-27       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.